Epuja Spiritech Ltd vs Omkar Pharmachem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 21, 2026

Key Highlights

The Latest Trading Price of Epuja Spiritech Ltd is ₹ 2.07 as of 20 Mar 15:30 . The P/E Ratio of Epuja Spiritech Ltd is 184 as of March 2025 .The P/E Ratio of Omkar Pharmachem Ltd is 0 as of March 2025 . The Market Cap of Epuja Spiritech Ltd is ₹ 30 crore as of March 2025 .The Market Cap of Omkar Pharmachem Ltd is ₹ 0 crore as of March 2025 . The revenue of Epuja Spiritech Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.12 crore. This represent the decline of -58.33% The revenue of Omkar Pharmachem Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Epuja Spiritech Ltd for the Dec '25 is ₹ -2.78 crore as compare to the Sep '25 ebitda of ₹ -1.24 crore. This represent the growth of 124.19% The ebitda of Omkar Pharmachem Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Epuja Spiritech Ltd changed from ₹ -0.41 crore to ₹ -2.78 crore over 7 quarters. This represents a CAGR of 198.54% The net profit of Omkar Pharmachem Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Epuja Spiritech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Omkar Pharmachem Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Epuja Spiritech Ltd

Sagar Productions Limited (Formerly known as Kirti Finvest Limited) was incorporated in 1980, which later on was changed to its present name 'Sagar Productions Limited' in May 2010.
The Company is engaged in financing share trading and investments in India.

About Omkar Pharmachem Ltd

Omkar Pharmachem Limited was incorporated on 31 March 1995.
The Company has not done any commercial activity during the year.
At present, it is incorporated with the object of doing business of pharmaceuticals and chemical product in 2017-18. The main objects of the Company are related to pharmaceuticals, chemicals and to provide Management and business support services.
Currently, Company is engaged in business of providing support services related activities.

FAQs for the comparison of Epuja Spiritech Ltd and Omkar Pharmachem Ltd

Which company has a larger market capitalization, Epuja Spiritech Ltd or Omkar Pharmachem Ltd?

Market cap of Epuja Spiritech Ltd is 17 Cr while Market cap of Omkar Pharmachem Ltd is 29 Cr

What are the key factors driving the stock performance of Epuja Spiritech Ltd and Omkar Pharmachem Ltd?

The stock performance of Epuja Spiritech Ltd and Omkar Pharmachem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Epuja Spiritech Ltd and Omkar Pharmachem Ltd?

As of March 21, 2026, the Epuja Spiritech Ltd stock price is INR ₹2.07. On the other hand, Omkar Pharmachem Ltd stock price is INR ₹29.5.

How do dividend payouts of Epuja Spiritech Ltd and Omkar Pharmachem Ltd compare?

To compare the dividend payouts of Epuja Spiritech Ltd and Omkar Pharmachem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.